June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Bidirectional retinal oculomics in Parkinson’s disease: A cross-sectional analysis of two cohorts
Author Affiliations & Notes
  • Siegfried Wagner
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    Institute of Ophthalmology, University College London, London, London, United Kingdom
  • David Romero-Bascones
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    Biomedical Engineering Department, Faculty of Engineering (MU-ENG), Mondragon Unibertsitatea, Mondragon, Pais Vasco, Spain
  • Mario Cortina Borja
    Great Ormond Street Institute of Child Health, University College London, London, London, United Kingdom
  • Dominic Williamson
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Robbert Struyven
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Yukun Zhou
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Paul Foster
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Unai Ayala
    Biomedical Engineering Department, Faculty of Engineering (MU-ENG), Mondragon Unibertsitatea, Mondragon, Pais Vasco, Spain
  • Miatane Barrenechea
    Biomedical Engineering Department, Faculty of Engineering (MU-ENG), Mondragon Unibertsitatea, Mondragon, Pais Vasco, Spain
  • Iñigo Gabilondo
    Ikerbasque, Bilbao, Bizkaia, Spain
  • Anthony Khawaja
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Praveen J Patel
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Jugnoo Rahi
    Great Ormond Street Institute of Child Health, University College London, London, London, United Kingdom
    Great Ormond Street Hospital for Children NHS Foundation Trust, London, London, United Kingdom
  • Alastair K Denniston
    University of Birmingham, Birmingham, Birmingham, United Kingdom
    University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham, United Kingdom
  • Axel Petzold
    Queen Square Institute of Neurology, University College London, London, London, United Kingdom
    Institute of Ophthalmology, University College London, London, London, United Kingdom
  • Pearse Keane
    Institute of Ophthalmology, University College London, London, London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Footnotes
    Commercial Relationships   Siegfried Wagner None; David Romero-Bascones None; Mario Cortina Borja None; Dominic Williamson None; Robbert Struyven None; Yukun Zhou None; Paul Foster None; Unai Ayala None; Miatane Barrenechea None; Iñigo Gabilondo None; Anthony Khawaja Abbvie, Aerie, Google Health, Novartis, Reichert, Santen, Thea, Code C (Consultant/Contractor); Praveen Patel None; Jugnoo Rahi None; Alastair Denniston None; Axel Petzold Novartis, Code C (Consultant/Contractor), Heidelberg Engineering, Roche, Code R (Recipient); Pearse Keane Apellis, Code C (Consultant/Contractor), Allergan, Topcon, Heidelberg Engineering, Novartis, Roche, Bayer, Code F (Financial Support), Big Picture Medical, Code I (Personal Financial Interest)
  • Footnotes
    Support  Medical Research Council Clinical Research Training Fellowship MR/TR000953/1
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 455. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Siegfried Wagner, David Romero-Bascones, Mario Cortina Borja, Dominic Williamson, Robbert Struyven, Yukun Zhou, Paul Foster, Unai Ayala, Miatane Barrenechea, Iñigo Gabilondo, Anthony Khawaja, Praveen J Patel, Jugnoo Rahi, Alastair K Denniston, Axel Petzold, Pearse Keane; Bidirectional retinal oculomics in Parkinson’s disease: A cross-sectional analysis of two cohorts. Invest. Ophthalmol. Vis. Sci. 2023;64(8):455.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dopaminergic impairment in Parkinson’s disease (PD) has been observed in the retina in cadaveric studies however it remains unclear whether this can be detected by in vivo imaging. We investigated inner retinal anatomy, measured using optical coherence tomography (OCT), in prevalent PD and subsequently assessed these markers as prognostic factors for the development of PD using a prospective research cohort.

Methods : This cross-sectional analysis used data from two studies. For the detection of retinal markers in prevalent PD, we used data from AlzEye, a retrospective cohort of 154,830 patients aged 40 years and over attending ophthalmic hospitals in London, UK from 2008-2018. For the evaluation of retinal markers as prognostic factors, we used data from United Kingdom Biobank (UKBB), a prospective population-based cohort where 67,311 volunteers aged 40-69 years were recruited from 2006-2010 and underwent retinal imaging. Retinal nerve fibre layer, ganglion cell-inner plexiform layer (mGC-IPL), and inner nuclear layer (INL) thicknesses were extracted from macula-centred OCT. Linear mixed effects models were fitted to examine the association between prevalent PD and retinal thicknesses. Hazard ratios (HR) for the association between time to PD diagnosis and retinal thicknesses were estimated using frailty models.

Results : Within the AlzEye cohort, there were 700 individuals with prevalent PD and 105,770 controls (mean age 65.5 +/- 13.5 years, 51.7% female). Individuals with prevalent PD had thinner mGC-IPL (-2.12 μm, 95%CI: -3.17, -1.07, p = 8.2×10-5) and INL (-0.99 μm, 95%CI: -1.52, -0.47, p = 2.1×10-4). The UKBB included 50,405 participants (mean age 56.1 +/- 8.2 years, 54.7% female), of whom 53 developed PD at a mean of 2653 +/- 851 days. Thinner mGC-IPL (HR: 0.62 per standard deviation increase, 95%CI: 0.46, 0.84, p=0.002) and thinner INL (HR: 0.70, 95%CI: 0.51, 0.96, p=0.026) were also associated with incident PD.

Conclusions : Our novel findings of reduced INL thickness in PD lend credence to a primary dopaminergic degeneration originating within the inner retina. Differences in thicknesses of the INL and mGC-IPL manifest early highlighting a potential role for retinal imaging for early detection and at-risk stratification for PD.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Summary of findings for prevalent and incident Parkinson’s disease. Values are shown per parafoveal region and for the average of all inner segments (small donut).

Summary of findings for prevalent and incident Parkinson’s disease. Values are shown per parafoveal region and for the average of all inner segments (small donut).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×